MAPK4 silencing in gastric cancer drives liver metastasis by positive feedback between cancer cells and macrophages
3
조회
0
다운로드
0
인용
0
참고문헌
초록
Liver metastasis is a major cause of death in gastric cancer patients, but the underlying mechanisms are poorly understood. Through a combination of in vivo screening and transcriptome profiling followed by quantitative RT-PCR and tissue array analyses, we found that mitogen-activated protein kinase 4 (MAPK4) downregulation in gastric cancer tissues from patients is significantly associated with liver metastasis and poor prognosis. The knockdown of MAPK4 in gastric cancer cells promotes liver metastasis in orthotopic mouse models. MAPK4 depletion in gastric cancer cells induces the secretion of macrophage migration inhibitory factor (MIF) to polarize tumor-associated macrophages (TAMs) in orthotopic xenograft tumors. Moreover, TAMs activate epithelial–mesenchymal transition of gastric cancer cells to suppress MAPK4 expression, which further increases MIF secretion to polarize TAMs. Taken together, our results suggest a previously undescribed positive feedback loop between cancer cells and macrophages mediated by MAPK4 silencing that facilitates gastric cancer liver metastasis.
Abstract
Liver metastasis is a major cause of death in gastric cancer patients, but the underlying mechanisms are poorly understood. Through a combination of in vivo screening and transcriptome profiling followed by quantitative RT-PCR and tissue array analyses, we found that mitogen-activated protein kinase 4 (MAPK4) downregulation in gastric cancer tissues from patients is significantly associated with liver metastasis and poor prognosis. The knockdown of MAPK4 in gastric cancer cells promotes liver metastasis in orthotopic mouse models. MAPK4 depletion in gastric cancer cells induces the secretion of macrophage migration inhibitory factor (MIF) to polarize tumor-associated macrophages (TAMs) in orthotopic xenograft tumors. Moreover, TAMs activate epithelial–mesenchymal transition of gastric cancer cells to suppress MAPK4 expression, which further increases MIF secretion to polarize TAMs. Taken together, our results suggest a previously undescribed positive feedback loop between cancer cells and macrophages mediated by MAPK4 silencing that facilitates gastric cancer liver metastasis.
참고문헌 (54)
- Sung, H., "Global Cancer Statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J. Clin, 71, pp.209~249 (2021)
- Yang, D., "Survival of metastatic gastric cancer : significance of age, sex and race", ethnicity, 2011, pp.2, 77~84
- Riihimaki, M., "Metastatic spread in patients with gastric cancer", Oncotarget, 7, pp.52307~52316 (2016)
- Zhang, Y., "A population-based analysis of distant metastasis in Stage IV gastric cancer", Med. Sci. Monit, 26, pp.e923867~ (2020)
- Valastyan, S., "Tumor metastasis: molecular insights and evolving paradigms", Cell, 147, pp.275~292 (2011)
- Duan, Q., "Turning cold into hot : firing up the tumor microenvironment", Trends Cancer, 6, pp.605~618 (2020)
- Nielsen, S. R., "Macrophages as key drivers of cancer progression and metastasis", Mediat. Inflamm, 2017, pp.9624760~ (2017)
- Nakamura, K, "Myeloid immunosuppression and immune checkpoints in the tumor microenvironment", Cell. Mol. Immunol, 17, pp.1~12 (2020)
- Sugimura, K., "High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer", J. Surg. Oncol, 111, pp.752~759 (2015)
- Yamaguchi, T., "Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination", Gastric Cancer, 19, pp.1052~1065 (2016)
- Zhu, Q., "Observation of tumor-associated macrophages expression in gastric cancer and its clinical pathological relationship", Medicine, 99, pp.e19839~ (2020)
- Su, S., "A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis", Cancer Cell, 25, pp.605~620 (2014)
- Harney, A. S., "Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA", Cancer Discov, 5, pp.932~943 (2015)
- Nielsen, S. R., "Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis", Nat. Cell Biol, 18, pp.549~560 (2016)
- Sarode, P., "Reprogramming of tumor-associated macrophages by targeting beta-catenin", FOSL2, Sci. Adv, pp.2020, 6[DOI]
- Lu, Y., "Twa1", Gid8 is a beta-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis, 2017, pp.27, 1422~1440
- Jiao, S., "A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer", Cancer Cell, 25, pp.166~180 (2014)
- Xing, R., "Gastrokine 1 induces senescence through p16", Rb pathway activation in gastric cancer cells, 2012, pp.61, 43~52
- Bruns, C. J., "In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice", Neoplasia, 1, pp.50~62 (1999)
- Pauli, B. U., "The isolation and characterization in vitro of normal epithelial cells, endothelial cells and fibroblasts from rat urinary bladder", Tissue Cell, 12, pp.419~436 (1980)
- Renaud, J., "Development of an insert co-culture system of two cellular types in the absence of cell–cell contact", J. Vis. Exp (2016)[DOI]
- Kumar, V., "Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors", Cancer Cell, 32, pp.654~668 (2017)
- Budczies, J., "Cutoff Finder : a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization", PLoS ONE, 7, pp.e51862~ (2012)
- Hidalgo, M., "Patient-derived xenograft models : an emerging platform for translational cancer research", Cancer Discov, 4, pp.998~1013 (2014)
- Lu, J., "Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer", J. Transl. Med, 13, pp.42~ (2015)
- Takahashi, K., "Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells", Oncogene, 37, pp.2757~2772 (2018)
- Kasashima, H., "Lysyl oxidase-like 2(LOXL2)from stromal fibroblasts stimulates the progression of gastric cancer", Cancer Lett, 354, pp.438~446 (2014)
- Joyce, J. A., "Microenvironmental regulation of metastasis", Nat. Rev. Cancer, 9, pp.239~252 (2009)
- Fukui, H., "IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling", Br. J. Cancer, 111, pp.763~771 (2014)
- Chanmee, T., "Tumor-associated macrophages as major players in the tumor microenvironment", Cancers, 6, pp.1670~1690 (2014)
- Chen, Y., "Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein", J. Hematol. Oncol, 10, pp.36~ (2017)
- Qian, B. Z., "Macrophage diversity enhances tumor progression and metastasis", Cell, 141, pp.39~51 (2010)
- Murray, P. J., "Macrophage polarization", Annu. Rev. Physiol, 79, pp.541~566 (2017)
- Sica, A., "Macrophage polarization in tumour progression", Semin. Cancer Biol, 18, pp.349~355 (2008)
- Yaddanapudi, K., "Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor", J. Immunol, 190, pp.2984~2993 (2013)
- 장호희, "Regulation of Protein Degradation by Proteasomes in Cancer", 대한암예방학회지, 23(4), pp.153~161 (2018), 대한암예방학회[DOI]
- Nguyen, L. K., "When ubiquitination meets phosphorylation : a systems biology perspective of EGFR", MAPK signalling, 2013, pp.11, 52~
- Schichl, Y. M., "Novel phosphorylation-dependent ubiquitination of tristetraprolin by mitogenactivated protein kinase", extracellular signal-regulated kinase kinase kinase 1(MEKK1)and tumor necrosis factor receptor-associated factor 2(TRAF2), 2011, pp.286, 38466~38477
- Kant, S., "Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5", J. Biol. Chem, 281, pp.35511~35519 (2006)
- Lambert, A. W., "Emerging biological principles of metastasis", Cell, 168, pp.670~691 (2017)
- Lu, W., "Epithelial–mesenchymal plasticity in cancer progression and metastasis", Dev. Cell, 49, pp.361~374 (2019)
- Zhang, J., "High infiltration of tumor-associated macrophages influences poor prognosis in human gastric cancer patients, associates with the phenomenon of EMT", Medicine, 95, pp.e2636~ (2016)
- Song, W. Z., "Translational significance for tumor metastasis of tumor-associated macrophages and epithelial–mesenchymal transition", Front. Immunol, 8, pp.1106~ (2017)
- Yang, M., "Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization", Mol. Cancer, 13, pp.43~ (2014)
- Ge, Z., "The crosstalk between tumor-associated macrophages(TAMs)and tumor cells and the corresponding targeted therapy", Front. Oncol, 10, pp.590941~ (2020)
- Bloom, B. R., "Mechanism of a reaction in vitro associated with delayed-type hypersensitivity", Science, 153, pp.80~82 (1966)
- Calandra, T., "Macrophage migration inhibitory factor : a regulator of innate immunity", Nat. Rev. Immunol, 3, pp.791~800 (2003)
- O’Reilly, C., "Targeting MIF in cancer : therapeutic strategies, current developments, and future opportunities", Med. Res. Rev, 36, pp.440~460 (2016)
- He, X. X., "Increased epithelial and serum expression of macrophage migration inhibitory factor(MIF)in gastric cancer : potential role of MIF in gastric carcinogenesis", Gut, 55, pp.797~802 (2006)
- Figueiredo, C. R., "Blockade of MIF-CD74 signalling on macrophages and dendritic cells restores the antitumour immune response against metastatic melanoma", Front. Immunol, 9, pp.1132~ (2018)
- Simpson, K. D., "Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment", J. Immunol, 189, pp.5533~5540 (2012)
- Aberg, E., "Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4", MAPK4, 2006, pp.281, 35499~35510
- Rousseau, J., "Targeted inactivation of Mapk4 in mice reveals specific nonredundant functions of Erk3", Erk4 subfamily mitogen-activated protein kinases, 2010, pp.30, 5752~5763
- Wang, W., "MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT", mTOR signaling, 2019, pp.129, 1015~1029
